European Regulator Starts Assessing Novavax’s Covid Vaccine—Stock Jumps 8%

European Regulator Starts Assessing Novavax’s Covid Vaccine—Stock Jumps 8%

The European Medicines Agency said it could make a decision on the shot “within weeks.”